Home/Filings/4/0001181431-07-065475
4//SEC Filing

SANDAGE BOBBY W PHD 4

Accession 0001181431-07-065475

CIK 0000854222other

Filed

Oct 31, 8:00 PM ET

Accepted

Nov 1, 5:18 PM ET

Size

8.3 KB

Accession

0001181431-07-065475

Insider Transaction Report

Form 4
Period: 2007-10-30
SANDAGE BOBBY W PHD
Executive Vice President
Transactions
  • Award

    Performance Rights

    2007-10-30+00 total
    Exp: 2010-10-30Common Stock (0 underlying)
  • Award

    Common Stock

    2007-10-30+13,50074,683 total
Footnotes (2)
  • [F1]Represents a grant of restricted stock that is subject to transfer restrictions, forfeiture and acceleration. The grant also vests in equal annual installments such that the transfer restrictions are removed relating to the shares as follows: one third (4,500 shares) annually for three years commencing one year from that date of grant.
  • [F2]Represents a grant of the right to receive shares of common stock subject to (i) achievement of certain milestones related to the market price of Indevus' Common Stock, and (ii) recipient remaining employed by Indevus on the three year anniversary of the date of grant. The number of shares the recipient is entitled to receive, if any, at such time is dependent on the market price at which Indevus' Common Stock trades for 20 consecutive business days at any time during the three year period prior to the vesting date. Depending on such prices as may be attained, the recipient could receive either (i) 13,500, (ii) 18,000 or (iii) 22,500 shares. Subject to certain acceleration events, if such market prices are not attained during such three year period, the recipient will not receive any shares under this award.

Issuer

INDEVUS PHARMACEUTICALS INC

CIK 0000854222

Entity typeother

Related Parties

1
  • filerCIK 0001046352

Filing Metadata

Form type
4
Filed
Oct 31, 8:00 PM ET
Accepted
Nov 1, 5:18 PM ET
Size
8.3 KB